Advertisement

New-Onset Atrial Fibrillation Among Patients With Infection in the Emergency Department: A Multicenter Cohort Study of 1-Year Stroke Risk

      Abstract

      Background

      Patients with new-onset atrial fibrillation in relation to infection are frequent in emergency departments (EDs) and may require antithrombotic therapy because of the increased risk of stroke. Our objective was to describe the 1-year risk of stroke in patients in the ED with infection, new-onset atrial fibrillation, and no antithrombotic therapy.

      Methods

      This was a population-based cohort study at 4 EDs in Denmark and Sweden. Atrial fibrillation was identified by electrocardiogram (ECG) upon arrival at the ED, and infection was identified by discharge diagnosis. Patient history was followed for 12 months or until initiation of oral anticoagulant therapy, ischemic stroke, or death. Primary outcome was stroke within 12 months compared to patients with infection and no atrial fibrillation.

      Results

      In the analysis, 15,505 patients were included; 48.7% were male and the median age was 71 (IQR, 56-83). Among the included patients, 2107 (13.6%) had atrial fibrillation of any kind and 822 (39.0%) of these had new-onset atrial fibrillation with a median CHA2DS2-VASc score of 3 (IQR 2-4).
      New-onset atrial fibrillation during infection showed an absolute postdischarge 1-year risk of stroke of 2.7% (95% CI 1.6-4.2), corresponding to a crude hazard ratio (HR) of 1.4 (95% CI 0.9-2.3), a sex and age adjusted HR of 1.0 (95% CI 0.6-1.6), and a CHA2DS2-VASc adjusted HR of 1.1 (95% CI, 0.7-1.8) compared to patients with infection but no atrial fibrillation.

      Conclusions

      Patients in the ED with infection and new-onset atrial fibrillation without current oral anticoagulant therapy had a 2.7% absolute 1-year risk of stroke. Stroke events were mainly related to sex and age and risk factors identified by the CHA2DS2-VASc score.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rietbrock S.
        • Heeley E.
        • Plumb J.
        • et al.
        Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme.
        Am Heart J. 2008; 156: 57-64https://doi.org/10.1016/j.ahj.2008.03.010
        • Lip G.Y.H.
        • Edwards S.J.
        Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.
        Thromb Res. 2006; 118: 321-333https://doi.org/10.1016/j.thromres.2005.08.007
        • Lip G.Y.H.
        • Nieuwlaat R.
        • Pisters R.
        • et al.
        Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
        Chest. 2010; 137: 263-272https://doi.org/10.1378/chest.09-1584
        • Kirchhof P.
        • Benussi S.
        • Kotecha D.
        • et al.
        2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
        Eur Heart J. 2016; 37: 2893-2962https://doi.org/10.1093/eurheartj/ehw210
        • January C.T.
        • Wann L.S.
        • Alpert J.S.
        • et al.
        2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
        J Am Coll Cardiol. 2014; 64: e1-76https://doi.org/10.1016/j.jacc.2014.03.022
        • Walkey A.J.
        • Wiener R.S.
        • Ghobrial J.M.
        • et al.
        Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis.
        JAMA. 2011; 306: 2248-2254https://doi.org/10.1001/jama.2011.1615
        • Walkey A.J.
        • Hammill B.G.
        • Curtis L.H.
        • et al.
        Long-term outcomes following development of new-onset atrial fibrillation during sepsis.
        Chest. 2014; 146: 1187-1195https://doi.org/10.1378/chest.14-0003
        • de Groot B.
        • van den Berg S.
        • Kessler J.
        • et al.
        Independent predictors of major adverse cardiovascular events in emergency department patients who are hospitalised with a suspected infection: a retrospective cohort study.
        BMJ Open. 2016; 6e009598https://doi.org/10.1136/bmjopen-2015-009598
        • Savelieva I.
        • Camm A.J.
        Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management.
        J Interv Card Electrophysiol Int J Arrhythm Pacing. 2000; 4: 369-382
        • Nørgaard B.
        • Mogensen C.B.
        • Teglbjærg L.S.
        • et al.
        Diagnostic packages can be assigned accurately in emergency departments. A multi-centre cohort study.
        Dan Med J. 2016; : 63
        • Lynge E.
        • Sandegaard J.L.
        • Rebolj M.
        The Danish National Patient Register.
        Scand J Public Health. 2011; 39: 30-33https://doi.org/10.1177/1403494811401482
      1. Rosso A. Validation of healthcare databases: why to do it and how to do it.

        • Pedersen C.B.
        The Danish Civil Registration System.
        Scand J Public Health. 2011; 39: 22-25https://doi.org/10.1177/1403494810387965
        • Ludvigsson J.F.
        • Otterblad-Olausson P.
        • Pettersson B.U.
        • et al.
        The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research.
        Eur J Epidemiol. 2009; 24: 659-667https://doi.org/10.1007/s10654-009-9350-y
        • Pottegård A.
        • Schmidt S.A.J.
        • Wallach-Kildemoes H.
        • et al.
        Data resource profile: The Danish National Prescription Registry.
        Int J Epidemiol. 2017; 46798-798fhttps://doi.org/10.1093/ije/dyw213
        • Astrand B.
        • Hovstadius B.
        • Antonov K.
        • et al.
        The Swedish National Pharmacy Register.
        2007: 129https://doi.org/10.3233/978-1-58603-774-1-345
        • Quan H.
        • Li B.
        • Couris C.M.
        • et al.
        Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.
        Am J Epidemiol. 2011; 173: 676-682https://doi.org/10.1093/aje/kwq433
        • Friberg L.
        • Rosenqvist M.
        • Lip G.Y.H.
        Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
        Eur Heart J. 2012; 33: 1500-1510https://doi.org/10.1093/eurheartj/ehr488
        • Gundlund A.
        • Kümler T.
        • Olesen J.B.
        • et al.
        Comparative thromboembolic risk in atrial fibrillation patients with and without a concurrent infection.
        Am Heart J. 2018; 204: 43-51https://doi.org/10.1016/j.ahj.2018.07.003
        • Adderley N.J.
        • Nirantharakumar K.
        • Marshall T.
        Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies.
        BMJ. 2018; 361: k1717
        • Go A.S.
        • Reynolds K.
        • Yang J.
        • et al.
        Association of Burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: The KP-RHYTHM study.
        JAMA Cardiol. 2018; 3: 601-608https://doi.org/10.1001/jamacardio.2018.1176
        • Klein Klouwenberg P.M.C.
        • Frencken J.F.
        • Kuipers S.
        • et al.
        Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis. A cohort study.
        Am J Respir Crit Care Med. 2017; 195: 205-211https://doi.org/10.1164/rccm.201603-0618OC
        • Henriksen D.P.
        • Nielsen S.L.
        • Laursen C.B.
        • et al.
        How well do discharge diagnoses identify hospitalised patients with community-acquired infections?--a validation study.
        PLoS One. 2014; 9e92891https://doi.org/10.1371/journal.pone.0092891
        • Rix T.A.
        • Riahi S.
        • Overvad K.
        • et al.
        Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry.
        Scand Cardiovasc J. 2012; 46: 149-153https://doi.org/10.3109/14017431.2012.673728
        • Johnsen S.P.
        • Overvad K.
        • Sørensen H.T.
        • et al.
        Predictive value of stroke and transient ischemic attack discharge diagnoses in The Danish National Registry of Patients.
        J Clin Epidemiol. 2002; 55: 602-607
        • Johansson L.
        • Norberg J.
        • Jansson J.-H.
        • et al.
        Estimating the prevalence of atrial fibrillation in a general population using validated electronic health data.
        Clin Epidemiol. 2013; 5: 475-481https://doi.org/10.2147/CLEP.S53420
        • Page R.L.
        • Wilkinson W.E.
        • Clair W.K.
        • et al.
        Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.
        Circulation. 1994; 89: 224-227